Ophthotech Targets Gene Therapy to Expand its Orphan and Age-Related Retinal Disease Strategy – Business Wire (press release)
|
Ophthotech Targets Gene Therapy to Expand its Orphan and Age-Related Retinal Disease Strategy
Business Wire (press release) NEW YORK–(BUSINESS WIRE)–Ophthotech Corporation (NASDAQ:OPHT) announced today that the Company has initiated an innovative gene therapy research collaboration focused on applying novel gene therapy technology to discover and develop next-generation … |
